RankAlpha logo
Back to Rankings

GALT

Galectin TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
GALT vs peer average
95/100
GALT vs. peer average (A vs. F)
Grade spread
D 3 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IFRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $273.23M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIFRXInflaRx
GALT
Galectin Therapeutics
IFRX
InflaRx
Grade
A
F
Momentum
99
17
Value
41
41
Sentiment
89
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs IFRX

GALT / IFRX
Grade Position
Above peers
GALT vs. peer average (A vs. F)
95/100
Momentum
99
GALT
Value
41
GALT
Sentiment
89
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GALT
1
IFRX
InflaRx NV Common
F
20/100
+4
2
SLGL
Sol-Gel Technologies Ltd Common
D
40/100
+3
3
TTRX
Turn Therapeutics Inc Common
F
20/100
+4
4
IKT
Inhibikase Therapeutics Inc Common
D
40/100
+3
5
SABS
SAB Biotherapeutics Inc Common
D
40/100
+3
IFRX is the first peer returned for this comparison set.